.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cerilliant
Cipla
Julphar
Mallinckrodt
QuintilesIMS
Johnson and Johnson
Healthtrust
Colorcon
US Department of Justice

Generated: June 26, 2017

DrugPatentWatch Database Preview

Bivalirudin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for bivalirudin and what is the scope of bivalirudin patent protection?

Bivalirudin
is the generic ingredient in two branded drugs marketed by Hospira Inc, The Medicines Co, Dr Reddys Labs Ltd, and Fresenius Kabi Usa, and is included in five NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for bivalirudin. Six suppliers are listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: bivalirudin

Tradenames:2
Patents:3
Applicants:4
NDAs:5
Drug Master File Entries: see list13
Suppliers / Packagers: see list6
Bulk Api Vendors: see list20
Clinical Trials: see list51
Patent Applications: see list4,138
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:bivalirudin at DailyMed

Pharmacology for Ingredient: bivalirudin

Tentative approvals for BIVALIRUDIN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe250MG/VIALINJECTABLE;INTRAVENOUS
► Subscribe► Subscribe250MGINJECTABLE;INJECTION
► Subscribe► Subscribe250MGINJECTABLE;INJECTION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
The Medicines Co
ANGIOMAX
bivalirudin
INJECTABLE;INTRAVENOUS020873-001Dec 15, 2000APRXYesYes7,582,727*PED► SubscribeY► Subscribe
Hospira Inc
BIVALIRUDIN
bivalirudin
INJECTABLE;INTRAVENOUS090811-001Jul 14, 2015APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
BIVALIRUDIN
bivalirudin
INJECTABLE;INTRAVENOUS090189-001Oct 28, 2016APRXNoNo► Subscribe► Subscribe
The Medicines Co
ANGIOMAX
bivalirudin
INJECTABLE;INTRAVENOUS020873-001Dec 15, 2000APRXYesYes7,598,343*PED► SubscribeY► Subscribe
Hospira Inc
BIVALIRUDIN
bivalirudin
INJECTABLE;INTRAVENOUS090816-001Jul 14, 2015APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: bivalirudin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
The Medicines Co
ANGIOMAX
bivalirudin
INJECTABLE;INTRAVENOUS020873-001Dec 15, 20005,196,404*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Fish and Richardson
Novartis
Johnson and Johnson
Merck
Farmers Insurance
Teva
Fuji
Chinese Patent Office
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot